Balchem Animal Nutrition & Health Launches Purachol Choline Chloride Line
New Hampton, New York. January 27, 2020. Balchem Corporation (NASDAQ: BCPC), a global nutrition and health company, today launched the new PuraChol line of branded choline products. As the global leader in choline production, Balchem has invested more than 50 years in research, manufacturing advances, raw ingredient testing and supplier relationship development to deliver the highest quality, purest choline chloride possible.
Available in multiple forms and carrier options, PuraChol is offered as:
- Liquid or dry formulations
- Non-grain, non-GMO
- Silica carrier
- Organic carrier
- Concentrations ranging from 50% to 75%
“Though the name PuraChol is new; customers can continue to expect the same premier quality and high standards they’ve come to know from Balchem,” says Jonathan Griffin, Vice President, GM of Balchem Animal Nutrition & Health. “We are building on Balchem’s long and distinguished history of scientific and manufacturing excellence with added transparency in our quality testing processes and enhanced supplier quality agreements; all to deliver a line of choline products with unmatched purity, safety and consistency.”
By adhering to rigorous quality testing protocols, maintaining complete supply chain control and manufacturing our products in world-class production facilities, our customers can be confident in PuraChol’s purity. Balchem’s extensive QC testing program analyzes raw materials and finished goods for a range of contaminants including dioxins, mycotoxins, pathogens and pesticides to ensure product quality and purity. Beginning in February 2020, Balchem will release the results of this testing program to customers on a quarterly basis.
The PuraChol difference extends beyond product-based characteristics to include intangibles like the consumer-driven areas of social responsibility, industry research support and environmental stewardship.
Balchem has taken the lead on choline research in both the human and animal sectors, establishing a scientific advisory board to help direct research toward better understanding of choline’s role in infant cognition, age-related cognitive decline and liver health in humans while seeking to better understand the impact of choline on epigenetic expression in animals.
To learn more about the new PuraChol choline line, Balchem’s new supplier code of conduct and sustainability report, visit Balchem.com.
Balchem Corporation reports four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. The Industrial Products segment manufactures and supplies certain derivative products into industrial applications.
This release contains forward-looking statements, which reflect Balchem’s expectation or belief concerning future events that involve risks and uncertainties. Balchem can give no assurance that the expectations reflected in forward-looking statements will prove correct and various factors could cause results to differ materially from Balchem’s expectations, including risks and factors identified in Balchem’s annual report on Form 10-K for the year ended December 31, 2018. Forward-looking statements are qualified in their entirety by the above cautionary statement. Balchem assumes no duty to update its outlook or other forward-looking statements as of any future date.
Contact: Scott Sorrell, Balchem Corporation / (845) 326-5603 / firstname.lastname@example.org